Cholesterol: Beyond the Numbers
October is National Cholesterol Month, led by HEART UK, the UK’s cholesterol charity. It is a timely moment to look beyond the familiar headline figures and consider what a cholesterol result actually tells us, and what it doesn’t.
Cholesterol is one of the most discussed topics in cardiovascular medicine. Yet the standard lipid panel, while a valuable starting point, captures only part of the picture. For patients who want to understand their cardiovascular risk more completely, there is considerably more to explore.
What a standard cholesterol test measures
A standard lipid panel measures total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides. These numbers are useful for population-level risk assessment and for identifying people who may benefit from treatment. But they have well-documented limitations at the individual level.
LDL cholesterol, often described simply as the ‘bad’ cholesterol, is in reality a measure of the amount of cholesterol carried within LDL particles rather than the number or size of those particles.
Research indicates that small, dense LDL particles may be a more significant predictor of cardiovascular risk than standard LDL cholesterol measurements, because smaller particles penetrate arterial walls more readily and contribute more to plaque formation. Two people can have the same LDL cholesterol reading yet carry very different levels of cardiovascular risk depending on their particle profile.
Additional markers such as apolipoprotein B (ApoB), which reflects the total number of atherogenic particles in the blood, and lipoprotein(a) or Lp(a), a genetically determined risk factor carried by roughly one in five people, are not captured on a standard panel. Evidence published in the Lancet Diabetes and Endocrinology (2023) has highlighted the importance of looking beyond standard reference intervals to better define cardiovascular risk at an individual level.
What drives cholesterol imbalance in the first place
A high LDL reading is not a diagnosis in itself. It is a signal that something in the body’s metabolic environment is contributing to an unfavourable lipid profile. Identifying that underlying driver is where the picture becomes considerably more useful.
Thyroid function is one important example. Hypothyroidism is recognised by both the American College of Cardiology and the American Heart Association as one of the most commonly encountered secondary causes of elevated LDL cholesterol and triglycerides. A 2024 review published in PMC confirmed that thyroid hormones play a crucial role in maintaining cardiovascular homeostasis, and that disruption to thyroid function can accelerate the progression of cardiovascular disease through multiple pathways including dyslipidaemia and increased insulin resistance.
Insulin resistance, chronic inflammation, dietary patterns high in ultra-processed foods, and excess visceral fat all contribute independently to cholesterol imbalance. Liver function matters too, as the liver is central to cholesterol synthesis, conversion and clearance. Looking at these factors together, rather than treating the cholesterol number as an isolated finding, is where a more complete picture begins to emerge.
A quote from Dr Grosser
“When I review a patient’s lipid results, the standard panel is just my starting point. I want to know about particle size, ApoB levels, Lp(a), inflammatory markers such as hs-CRP, and whether insulin resistance is part of the picture. I also want to understand thyroid function, liver health and dietary patterns, because all of these influence what the body does with cholesterol. Treating a number without understanding what is producing it means we may be missing the most important part of the conversation.”
Dr Grosser’s consultations at KentCardio consider advanced lipid profiles alongside conventional cardiovascular risk assessment, looking at the full range of metabolic, inflammatory and lifestyle factors that shape an individual’s lipid biology. For patients whose cholesterol results feel difficult to interpret, or who want to understand what is driving their risk, this kind of comprehensive assessment can offer considerably more than a standard panel alone.
This article is for general information and does not constitute medical advice.
Book a consultation with Dr Konrad Grosser at KentCardio: https://kentcardio.com/book/
